Chamberlain College of Nursing | NR 607 Diagnosis & Management in Psychiatric-Mental
Health III
NR 607 Diagnosis & Management in
Psychiatric-Mental Health III Final
Comprehensive Examination 2026/2027 |
Verified Questions
Chamberlain College of Nursing | NR 607 Diagnosis & Management in Psychiatric-Mental Health III |
University-Level Advanced Practice Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 607 Diagnosis & Management in Psychiatric-Mental Health III
Final Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 607 Diagnosis & Management in Psychiatric-Mental Health III Final Comprehensive Examination 2026/2027 | Verified
Questions
,INTRODUCTION
This comprehensive examination contains 100 original verified questions designed for university-level
advanced nursing students preparing for the NR 607 Diagnosis & Management in Psychiatric-Mental
Health III Final Comprehensive Examination. The questions are distributed equally across four core
domains: Mood, Anxiety, and Trauma-Related Disorders (25 questions), Psychotic, Cognitive, and
Neurodevelopmental Disorders (25 questions), Substance Use, Addictive, and Eating Disorders (25
questions), and Special Populations, Ethics, and Psychopharmacology (25 questions). Content is original
and structured to reinforce official Chamberlain College of Nursing NR 607 course objectives for actual
exam readiness and clinical proficiency, aligned to the 2026/2027 academic year. Each question includes
a correct answer and a clinical rationale grounded in diagnostic criteria, psychopharmacology, and
evidence-based clinical care standards.
ACTUAL QUESTIONS
Domain 1: Mood, Anxiety, and Trauma-Related Disorders
Question 1. A client presents with depressed mood, anhedonia, significant weight loss,
insomnia, fatigue, and recurrent thoughts of death lasting for six weeks. Which DSM-5
diagnosis is most consistent with these findings?
A. Adjustment disorder with depressed mood
B. Major depressive disorder
C. Persistent depressive disorder
D. Bipolar II disorder
Correct Answer: D
Rationale: Major depressive disorder requires a two-week (or longer) period of depressed mood or
anhedonia plus additional symptoms causing clinically significant distress or impairment.
Question 2. Which medication class is considered first-line pharmacologic treatment for
moderate to severe major depressive disorder in adults?
A. Tricyclic antidepressants
B. Monoamine oxidase inhibitors
C. Selective serotonin reuptake inhibitors
D. Typical antipsychotics
Correct Answer: B
Rationale: SSRIs are first-line due to favorable efficacy, tolerability, and safety profile compared with
older agents.
Question 3. A client with bipolar I disorder presents in a manic episode with elevated
mood, decreased need for sleep, pressured speech, and risky behavior. Which mood
stabilizer has the strongest evidence for acute mania?
A. Lamotrigine
B. Lithium
C. Buspirone
D. Fluoxetine
Correct Answer: D
Rationale: Lithium remains a first-line agent with robust evidence for acute mania and maintenance
treatment in bipolar I disorder.
Question 4. Which symptom is required for a diagnosis of generalized anxiety disorder?
A. Panic attacks
NR 607 Diagnosis & Management in Psychiatric-Mental Health III Final Comprehensive Examination 2026/2027 | Verified
Questions
, B. Excessive anxiety and worry occurring more days than not for at least six months about a number
of events or activities
C. Obsessions and compulsions
D. Flashbacks of a traumatic event
Correct Answer: C
Rationale: GAD is characterized by persistent, excessive, difficult-to-control worry lasting at least six
months accompanied by associated symptoms.
Question 5. A client who experienced a life-threatening event one month ago now reports
intrusive memories, avoidance of reminders, negative alterations in cognition and mood,
and hyperarousal. Which diagnosis is most appropriate?
A. Acute stress disorder
B. Posttraumatic stress disorder
C. Adjustment disorder
D. Specific phobia
Correct Answer: B
Rationale: PTSD requires symptom duration of more than one month following exposure to actual or
threatened death, serious injury, or sexual violence.
Question 6. Which medication is FDA-approved for the treatment of PTSD and is an SSRI?
A. Venlafaxine
B. Sertraline
C. Bupropion
D. Mirtazapine
Correct Answer: D
Rationale: Sertraline (and paroxetine) are FDA-approved SSRIs for PTSD; sertraline is commonly used
as first-line pharmacotherapy.
Question 7. A client with panic disorder experiences recurrent unexpected panic attacks
followed by persistent concern about additional attacks. Which of the following is a core
feature of a panic attack?
A. Gradual onset over hours
B. Abrupt surge of intense fear or discomfort that peaks within minutes
C. Only occurring in response to a specific phobic stimulus
D. Absence of physical symptoms
Correct Answer: B
Rationale: Panic attacks are discrete periods of intense fear with abrupt onset and rapid peak,
accompanied by multiple physical and cognitive symptoms.
Question 8. Which laboratory monitoring is essential for a client started on lithium?
A. Liver enzymes only
B. Serum lithium level, renal function, and thyroid function
C. Complete blood count weekly
D. Serum amylase
Correct Answer: A
Rationale: Lithium requires monitoring of serum levels (narrow therapeutic index), renal function
(renal clearance), and thyroid function (risk of hypothyroidism).
Question 9. A client with bipolar disorder is prescribed lamotrigine. The most important
counseling point regarding titration is:
A. Rapid titration is preferred to achieve therapeutic effect quickly
NR 607 Diagnosis & Management in Psychiatric-Mental Health III Final Comprehensive Examination 2026/2027 | Verified
Questions
Health III
NR 607 Diagnosis & Management in
Psychiatric-Mental Health III Final
Comprehensive Examination 2026/2027 |
Verified Questions
Chamberlain College of Nursing | NR 607 Diagnosis & Management in Psychiatric-Mental Health III |
University-Level Advanced Practice Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 607 Diagnosis & Management in Psychiatric-Mental Health III
Final Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 607 Diagnosis & Management in Psychiatric-Mental Health III Final Comprehensive Examination 2026/2027 | Verified
Questions
,INTRODUCTION
This comprehensive examination contains 100 original verified questions designed for university-level
advanced nursing students preparing for the NR 607 Diagnosis & Management in Psychiatric-Mental
Health III Final Comprehensive Examination. The questions are distributed equally across four core
domains: Mood, Anxiety, and Trauma-Related Disorders (25 questions), Psychotic, Cognitive, and
Neurodevelopmental Disorders (25 questions), Substance Use, Addictive, and Eating Disorders (25
questions), and Special Populations, Ethics, and Psychopharmacology (25 questions). Content is original
and structured to reinforce official Chamberlain College of Nursing NR 607 course objectives for actual
exam readiness and clinical proficiency, aligned to the 2026/2027 academic year. Each question includes
a correct answer and a clinical rationale grounded in diagnostic criteria, psychopharmacology, and
evidence-based clinical care standards.
ACTUAL QUESTIONS
Domain 1: Mood, Anxiety, and Trauma-Related Disorders
Question 1. A client presents with depressed mood, anhedonia, significant weight loss,
insomnia, fatigue, and recurrent thoughts of death lasting for six weeks. Which DSM-5
diagnosis is most consistent with these findings?
A. Adjustment disorder with depressed mood
B. Major depressive disorder
C. Persistent depressive disorder
D. Bipolar II disorder
Correct Answer: D
Rationale: Major depressive disorder requires a two-week (or longer) period of depressed mood or
anhedonia plus additional symptoms causing clinically significant distress or impairment.
Question 2. Which medication class is considered first-line pharmacologic treatment for
moderate to severe major depressive disorder in adults?
A. Tricyclic antidepressants
B. Monoamine oxidase inhibitors
C. Selective serotonin reuptake inhibitors
D. Typical antipsychotics
Correct Answer: B
Rationale: SSRIs are first-line due to favorable efficacy, tolerability, and safety profile compared with
older agents.
Question 3. A client with bipolar I disorder presents in a manic episode with elevated
mood, decreased need for sleep, pressured speech, and risky behavior. Which mood
stabilizer has the strongest evidence for acute mania?
A. Lamotrigine
B. Lithium
C. Buspirone
D. Fluoxetine
Correct Answer: D
Rationale: Lithium remains a first-line agent with robust evidence for acute mania and maintenance
treatment in bipolar I disorder.
Question 4. Which symptom is required for a diagnosis of generalized anxiety disorder?
A. Panic attacks
NR 607 Diagnosis & Management in Psychiatric-Mental Health III Final Comprehensive Examination 2026/2027 | Verified
Questions
, B. Excessive anxiety and worry occurring more days than not for at least six months about a number
of events or activities
C. Obsessions and compulsions
D. Flashbacks of a traumatic event
Correct Answer: C
Rationale: GAD is characterized by persistent, excessive, difficult-to-control worry lasting at least six
months accompanied by associated symptoms.
Question 5. A client who experienced a life-threatening event one month ago now reports
intrusive memories, avoidance of reminders, negative alterations in cognition and mood,
and hyperarousal. Which diagnosis is most appropriate?
A. Acute stress disorder
B. Posttraumatic stress disorder
C. Adjustment disorder
D. Specific phobia
Correct Answer: B
Rationale: PTSD requires symptom duration of more than one month following exposure to actual or
threatened death, serious injury, or sexual violence.
Question 6. Which medication is FDA-approved for the treatment of PTSD and is an SSRI?
A. Venlafaxine
B. Sertraline
C. Bupropion
D. Mirtazapine
Correct Answer: D
Rationale: Sertraline (and paroxetine) are FDA-approved SSRIs for PTSD; sertraline is commonly used
as first-line pharmacotherapy.
Question 7. A client with panic disorder experiences recurrent unexpected panic attacks
followed by persistent concern about additional attacks. Which of the following is a core
feature of a panic attack?
A. Gradual onset over hours
B. Abrupt surge of intense fear or discomfort that peaks within minutes
C. Only occurring in response to a specific phobic stimulus
D. Absence of physical symptoms
Correct Answer: B
Rationale: Panic attacks are discrete periods of intense fear with abrupt onset and rapid peak,
accompanied by multiple physical and cognitive symptoms.
Question 8. Which laboratory monitoring is essential for a client started on lithium?
A. Liver enzymes only
B. Serum lithium level, renal function, and thyroid function
C. Complete blood count weekly
D. Serum amylase
Correct Answer: A
Rationale: Lithium requires monitoring of serum levels (narrow therapeutic index), renal function
(renal clearance), and thyroid function (risk of hypothyroidism).
Question 9. A client with bipolar disorder is prescribed lamotrigine. The most important
counseling point regarding titration is:
A. Rapid titration is preferred to achieve therapeutic effect quickly
NR 607 Diagnosis & Management in Psychiatric-Mental Health III Final Comprehensive Examination 2026/2027 | Verified
Questions
